ArticleOncotarget2016

Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.

Jianyong Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.